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Abstract
Rationale: With the advent of primary PCI (PPCI), reperfusion is achieved in almost all patients presenting with acute
myocardial infarction. However, despite multiple trials, reperfusion injury has not been successfully dealt with so far. In
mouse models, CD4+ T lymphocytes (T cells) have been shown to be crucial instigators of reperfusion injury.
Objective: Our goal was to investigate the role of CD4+ T cells during myocardial reperfusion following PPCI by developing
a protocol for high-throughput multiplexed flow cytometric analysis and multivariate flow clustering.
Methods and Results: 13-parameter immunophenotyping and hierarchical cluster analysis (HCA) identified a unique
CD4+CD57+ T-cell population in PPCI patients that reflected acute proliferation in the CD4+ T-cell compartment. CD4+CCR7+
T cells were specifically depleted from peripheral blood during the first 30 min of myocardial reperfusion after PPCI,
suggesting a potential role for the chemokine receptor CCR7 in T-cell redistribution to either peripheral tissues or migration
to the infarcted heart during ischemia/reperfusion following PPCI.
Conclusions: High-throughput polychromatic flow cytometry and HCA are capable of objective, time and cost efficient
assessment of the individual T-cell immune profile in different stages of coronary heart disease and have broad applications
in clinical trials.
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Introduction
In patients with acute ST-elevation myocardial infarction
(STEMI), early and successful reopening of the infarct related
coronary vessel by primary percutaneous coronary intervention
(PPCI) is the most effective treatment strategy proven so far.
Myocardial reperfusion, however, can induce myocardial injury
and cell death. Neutrophil granulocytes, migrating into the
myocardium, are believed to mediate cardiomyocyte death by
microvascular obstruction (MVO) and generation of ROS
(reactive oxygen species). MVO is associated with larger infarct
size, adverse left ventricular remodelling and more frequent
adverse cardiovascular outcomes [1]. In patients with STEMI
treated with PPCI, up to 40% of patients have impaired
microvascular perfusion [2–4]. Nonetheless, the treatment of
MVO, which is associated with the ‘‘no-reflow’’ phenomenon,
remains elusive. Studies in animal models of acute myocardial
infarction suggest that reperfusion injury is a major determinant of
final infarct size. In patients with STEMI, PPCI has reduced in-
hospital mortality to as low as 5%. However, a significant
proportion of patients will suffer from post-infarction heart failure
or die in due course from complications related to left ventricular
dysfunction. Therefore, future therapies for STEMI have to target
causes of post-infarction heart failure, including myocardial
reperfusion injury.
Mouse studies have generated evidence that in kidney, lung and
myocardial ischemia-reperfusion (I/R) injury T lymphocytes (T
cells) are the important effectors [5–7]. Studies in a mouse model
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of I/R have revealed that CD4+ T cells, but not CD8+ T cells,
invade the infarcted myocardium, triggering the influx of
neutrophils from the bone marrow [8,9]. The role of T cells in
acute reperfusion of STEMI in humans has not been investigated
in detail so far. Two studies have shown the adverse prognostic
relevance of lymphopenia during the first 96 h of STEMI [10,11].
However, no study so far has looked into the regulation of specific
lymphocyte populations during STEMI and especially the
reperfusion phase. This is becoming increasingly more important
due to the widespread use of PPCI especially in North America
and the UK, where thrombolytic therapy has been replaced as the
treatment of choice over the last 4 years.
In this study, we describe a novel detailed protocol for
immunostaining and high-throughput multiparameter flow cyto-
metric analysis of peripheral blood T-cell subsets and its potential
applications for a multicenter clinical trial. By using an extended
panel of monoclonal antibodies targeting differentiation and
senescence surface markers, we were able to dissect out
immunophenotypic profiles of several T-cell subsets in patients
with acute myocardial infarction following PPCI. Application of a
novel multivariate-clustering algorithm enabled an a priori objec-
tive screening to identify differences in immunophenotypic and
functional T-cell profiles in patients with coronary heart disease.
Materials and Methods
Please see online Materials S1 for further details.
Ethics Statement
The study protocol was approved by the institutional ethical
committee of Newcastle University (REC 09/H0905/50), and
written informed consent was obtained from all patients and
healthy volunteers.
Study subjects
55 men with angiographically confirmed coronary heart disease
were included into the study. 31 patients with acute ST-elevation
myocardial infarction (STEMI, mean age 56.265.6 years) and 24
stable patients with healed STEMI (mean time 6 months after
infarction, mean age 6166 y) were analysed 24 hours following
primary coronary intervention (PPCI) or routine coronary angiog-
raphy, respectively (Table 1). None of the patients were affected by
neoplastic, autoimmune or chronic infectious disease. All subjects
with recent infections were also excluded. 18 healthy male volunteers
were enrolled as controls (mean age 53.565.8 y). For the time-
course additional 17 patients with STEMI (mean age 61.5 years)
were sequentially analysed within 48 hours following PPCI (Table 2).
Table 1. Clinical patient characteristics of the main study group.
STEMI, 24 h post PCI Stable, .3 months post STEMI
n 31 24
Age, years, median (range) 58.1 (45–65) 61.8 (47–74)
Sex: M/F 31/0 24/0
Initial troponin I, ng/L 7.462.9 NA
Peak troponin I, ng/L 35.763.3 NA
CK, U/L 4206653 NA
Number of vessels (1/2/3) 19/7/5 6/4/14
TIMI flow before PCI (0/1/2/3) 26/0/4/1 NA
Onset-to-balloon time, min 194628 NA
Door-to-balloon time, min 2662 NA
Ejection fraction, % 4662* 3864
Risk factors
HDL cholesterol, mmol/L 1.160.04 4.260.05
LDL cholesterol, mmol/L 3.960.2 3.160.3
Triglycerides, mmol/L 1.660.2 2.160.2
Dyslipidemia 7/31 11/24
BMI 28.760.9 29.461.3
Diabetes 3/31 8/24
Hypertension 7/31 14/24
Current smoking 14/31 3/31
Family history of CHD 18/31 11/24
History
Previous MI 1/31 24/24
Previous CABG 0/31 6/24
Previous PCI 2/31 24/24
Statins 6/31 23/24
CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; CHD: coronary heart disease; MI: myocardial infarction; NA: not applicable.
*For STEMI patients ejection fraction 3 days after event.
doi:10.1371/journal.pone.0047155.t001
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Blood Collection and enumeration of peripheral blood
leukocyte subsets
80 ml or 20 ml (for the time-course substudy) of peripheral
blood were drawn into EDTA collection tubes. Absolute counts of
peripheral blood granulocytes, monocytes and lymphocyte
subpopulations were determined directly using 5-colour BD
TruCount flow cytometry assay (BD Biosciences).
PBMCs isolation, cell cryopreservation and storage
Peripheral blood mononuclear cells (PBMCs) were obtained
after Ficoll density gradient centrifugation using Ficoll-Hypaque.
Following isolation, PBMCs were counted using a Neubauer
haemocytometer, carefully resuspended in ice-chilled freezing
medium containing RPMI 1640 with 10% FBS, 1% P/S and 10%
DMSO (100 ml medium pro 16106 cells) and aliquoted into 1 ml
cryovials. Cell aliquots were frozen at 280uC using 1uC freezing
containers with isopropyl alcohol (Thermo Fisher Scientific), and
stored at 280uC for no longer than 6 months.
Cell staining for 11-colour flow cytometry and flow
cytometry data acquisition
Frozen PBMC aliquots were quickly thawed, and washed once
using automatic cell washer. Following primary wash step, cell
viability and cell numbers were analysed using Vi cell counter.
16106 PBMCs were then incubated with the primary antibody
mix for 20 minutes at RT in the dark. Following three wash steps,
the secondary conjugates and Aqua dead cell dye (Invitrogen) were
added. Samples were incubated in the dark for another 20 minutes
at RT. Following final wash steps unfixed samples were
immediately subjected to analysis by flow cytometry. Samples
were measured in our flow core facility on a BD LSR II cytometer
(see supplementary material for detailed description) using BD
FACSDiva acquisition software. PMT voltages and compensation
values were set as described below. At least 100.000 viable cell
events per sample were acquired.
Flow cytometry data analysis
The analysis of acquired data was performed using MATLAB
(for Hierarchical Cluster Analysis, see below) or FlowJo software
(Version 9.4.1 for Macintosh). Two-dimensional plots (pseudo-
color or dot plot) were created using biexponential transformation
and sequential gating of viable T cells was performed according to
the model of T-cell memory differentiation as described by
Sallusto and Romero [12,13].
Hierarchical Cluster Analysis (HCA) of flow cytometry
data
Following data acquisition, files were exported from DIVA and
saved as .fcs version 3.0 files. The analysed parameters were eleven
colour channels (KLRG1, CD3, CD28, CCR7, CD45RA, CD57,
CD27, CD4, CD8, PD1, Aqua Dye) and 3–4 parameters based on
forward and side scatters (FS-A, SS-A, SS-H, (SS-W)). The raw or
CD3+ positive cells pre-gated data were extracted from .fcs files
and imported into MATLAB environment (MATLAB, Math-
Works, Natick, MA), where all subsequent steps were carried out.
Compensation matrix (as present in .fcs files) was applied to the
data followed by biexponential-like transformation and normal-
isation (zscore). After this the data were ready for HCA, which was
performed using our new algorithm described previously [14].
6-colour flow sorting of CD4 T Cells
36107 cryopreserved PBMCs were used for fluorescence-
activated cell sorting. PBMC staining was performed using anti-
human-CD3-FITC, CD4-PE-Cy7, CD8-APC-H7, CCR7-PE,
CD45RA-Pacific Blue and Aqua dead cell dye. Cell sorting was
performed in our flow core facility on a BD FACS Aria II cell
sorter. The sorted aliquots were spun down and the flow buffer
supernatant was completely removed with a vacuum suction. Dry
T-cell pellets were stored at 280uC freezer until further processed
with DNA isolation protocol (see below).
DNA isolation and telomere length RT-PCR assay
DNA was extracted from sorted CD4+ T cells with the QIAamp
DNA Mini Kit (Cat. No. 51304, Qiagen Ltd, Crawley, UK).
Telomere length was measured by quantitative real-time poly-
merase chain reaction (PCR) with modifications as described
previously [15].
Statistical analysis
In the text, data are reported as mean6SE. Comparison of 3
means was performed by ANOVA, followed by Tukeys’ post-hoc
test. Comparison of 2 groups was calculated using an unpaired t-
test, if normal probability plots (P-P plots) demonstrated approx-
imate normality. All statistical tests were performed using
GraphPad Prism version 5 for Macintosh (www.graphpad.com).
Table 2. Clinical patient characteristics of the time course
substudy group.
STEMI, time course substudy
n 17
Age, years, median (range) 63 (48–78)
Sex: M/F 10/7
Troponin T on admission, ng/L 100629
Troponin T at 12 h, ng/L 32016839
CK, U/L 133619
Number of vessels (1/2/3) 17/0/0
TIMI flow before PCI (0/1/2/3) 13/0/2/2
Onset-to-balloon time (min) 196620
Door-to-balloon time (min) 2863
Ejection fraction, % 4763
Risk factors
HDL cholesterol (mmol/L) 1.460.1
LDL cholesterol (mmol/L) 4.060.3
Triglycerides (mmol/L) 1.860.3
Dyslipidemia 2/17
BMI 26.761.4
Diabetes 0/17
Hypertension 5/17
Current smoking 10/17
Family history of CHD 11/17
History
Previous MI 2/17
Previous CABG 0/17
Previous PCI 2/17
Statins 1/17
CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention;
CHD: coronary heart disease; MI: myocardial infarction; NA: not applicable.
doi:10.1371/journal.pone.0047155.t002
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Figure 1. Peripheral leukocytosis after primary percutaneus coronary intervention (PPCI). Absolute number of total leukocytes,
neutrophil granulocytes and monocytes (A), as well as lymphocytes and the main T-cell subsets (B) in peripheral blood. Concentration of leukocyte
populations are displayed for patients 24 h following PPCI in STEMI (n = 31), 3 months post PPCI (n = 24), and in age-matched healthy Controls
(n = 18). 1-way ANOVA with Tukeys’ post-hoc test was performed. *p,0.05, ***p,0.001, ns not significant.
doi:10.1371/journal.pone.0047155.g001
Figure 2. Basic gating strategy for CD4+ T cells. Viable cells, as distiguished on the basis of Aqua dye staining were gated and CD4+ T cells were
selected based on their light scatter properties and CD3 and CD4 co-expression. CD4+ T-cell subpopulations were separated into main subsets based
on the CD45RA/CCR7 expression properties, as previously described by Sallusto et al.: NAIVE (CD45RA+CCR7+), CENTRAL MEMORY (CD45RA2CCR7+),
EFFECTOR MEMORY (CD45RA2CCR72) and CD45RA reexpressing ’’revertant’’ memory CD4+ T cells (T effector memory CD45RA+ cells, TEMRA).
Further sequential gating analysis were perfomed based on the coexpression of co-stimulatory markers CD27/CD28 as well as proliferation/
senescence markers CD57, KLRG1, and PD1.
doi:10.1371/journal.pone.0047155.g002
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Results
CD4 central memory T cells are elevated during the first
24 h after PPCI
To investigate the pattern of CD4+ T cells following PPCI, we
compared leukocyte subsets from 18 age-matched healthy controls
to patients with acute myocardial infarction following PPCI (24 h,
n = 31 and 6 months, n = 24) (Figure 1). While total leukocytes
(1241863969 vs. 650261845 cells/ml, p,0.001 vs. control),
granulocytes (898763448 vs. 373261277 cells/ml, p,0.001 vs.
control) and monocytes (8736330 vs. 4736191 cells/ml, p,0.001
vs. control) were all elevated 24 h following PPCI (Figure 1A), no
significant changes appeared in the lymphocyte population or
CD4 subpopulation, respectively (Figure 1B). At 6 months
following PPCI, only granulocytes appeared slightly elevated
(570061300 vs. 370061300 cells/ml, p,0.05 vs. control). Further
separation of CD4+ T cells into naı¨ve, central memory (CM),
effector memory (EM) and terminally differentiated EM cells
(TEMRA) was performed by adding antibodies for the chemokine
receptor CCR7 and CD45RA (Figure 2). Surprisingly, a 56%
relative increase in central memory cells compared to the control
group was now apparent at the 24 h time point (41610% vs.
2767%, p,0.001, Figure 3). 6 months post PPCI this increase
was no longer detectable (28610%, p,0.001 vs. 24 h, Figure 3).
Parallel to the relative increase of CD4+ CM cells we saw a
decrease in naive and TEMRA cells (Figure 3). Thus, these results
indicate a specific shift within the CD4+ T-cell population as the
result of either infarct vessel occlusion or reperfusion by PPCI.
13-parameter immunophenotyping and hierarchical
cluster analysis identifies a unique CD4+CD57+ T-cell
population in STEMI patients
We have developed a protocol, which allows for accurate 13-
parameter polychromatic analysis of cryopreserved mononuclear
cells even months after cell isolation. To test inter-assay variability,
we processed cryopreserved samples from the same donor on 27
different days (Table 4 in Materials S1). CV for % CD4+ out of all
T cells was 5.8%, and CVs for the 3 main populations (naı¨ve, CM
and EM) of CD4 T cells between 6 and 9%. Of note, CVs of
absolute CD4+ and CD8+ T-cell numbers from fresh blood were
below 2% (data not shown).
After processing all 73 cryopreserved samples from controls and
patients, hierarchical clustering analysis (HCA) was used to
visualize differential cell populations between patients and
controls. HCA builds a hierarchical tree of nested clusters
(populations) based on their similarities (Figure 4A). This
hierarchical tree (or dendrogram) is drawn next to a heatmap
table. The identified clusters can be additionally plotted on
conventional two-dimensional dot blots (Figure 4B). In our study
population, we could identify a CD4+CD57+ cluster among all T
cells that appeared specific for patients following PPCI (Figure 4A).
Figure 3. Distribution of main CD4 T-cell subsets. Frequencies of CD4+ naive (CD45RA+CCR7+), central memory (CD45RA2CCR7+), effector
memory (CD45RA2CCR72) and terminally differentiated effector memory TEMRA cells (CD45RA+CCR72) are shown. Groups are identical to Figure 1.
1-way ANOVA with Tukeys’ post-hoc test was performed. *p,0.05, ***p,0.001, ns not significant.
doi:10.1371/journal.pone.0047155.g003
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This HCA-defined CD4+CD57+ cluster is characterized by
CD3+CD4+CD82CD45RA2CCR7+KLRG12CD57+ staining
(all two-parameter combination plots of a defined cluster are
shown in Figure 4 C). In terms of T-cell subpopulations, this
identifies CD4+ central memory cells that are staining positive for
CD57 and negative for KLRG1.
Increased expression of CD57 in central memory cells
indicates acute proliferation in the CD4 T-cell
compartment
Both CD57 and KLRG1 have been dubbed senescence
markers, however, CD57 expression on CD4+ T cells is a general
marker of proliferative inability, a history of more cell divisions,
and short telomeres [16]. The lack of KLRG1 expression in the
CD57+ CM subpopulation indicates very recent cell proliferation
without reaching senescence (Figure 5A) [16–18]. Next we
compared the mean fluorescence intensity (MFI) for 3 different
proliferation/senescence markers in CD4+ CM cells. While MFI
for CD57 increased from 235660 to 4196160 in patients 24 h
post PPCI (Figure 5B, p,0.001), MFI for PD-1 and KLRG1
remained unchanged. This strongly suggests a specific upregula-
tion of CD57 secondary to proliferation. To further lend proof to
this hypothesis, we measured MFIs in the 4 major subpopulations
of CD4+ T cells from healthy controls (Figure 5C). CD57 MFI for
naive CD4+ cells (202639) and CM cells (232661) did not differ,
while MFI in EM (5066263, p = 0.01 vs. naive) and TEMRAs
(557163928, p = 0.001 vs. naive) was significantly higher than in
naive cells. This analysis strongly suggests, that the increase in
CD57 MFI in PPCI patients is not simply due to a shift in
subpopulations, but the result of a real increase in numbers of
completed cell divisions. Interestingly, while CD57 MFI seems to
distinguish very well between EM and TEMRAs (p = 0.001), PD-1
and KLRG1 separate CM and EM populations well (Figure 5C).
To document that the increase in CD4+CD57+ CM T cells is not
just a relative shift, we analysed the total number of cells in
peripheral blood. Here we found an increase of
CD4+CD57+KLRG12 central memory cells from 864 cells/ml
Figure 4. Hierarchical clustering analysis of 13-parameter flow cytometry data. Dendrogram with heatmap-HCA of 104 events (gated on
viable CD3+ T cells) acquired from PBMCs of healthy control and STEMI patient (24 h after PPCI). Heatmap shows relative levels of all 13 parameters
(columns) in all 104 events (rows) in color coding (blue, low expression; red, high expression). Dendrogram shows the hierarchy of T cells based on
their similarity in all parameters measured. Colored branches of the dendrogram are selected clusters (A). The T-cell subsets from healthy controls (as
identified by HCA) are displayed on conventional scatter dot plots (B). HCA revealed that the proliferation marker CD57 is strongly expressed on CD4+
CM T cells in STEMI patients (zoom on cluster of interest in C).
doi:10.1371/journal.pone.0047155.g004
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to 23 cells/ml (p,0.001, Figure 5D). Finally, CD4+ T cells were
sorted from cryopreserved mononuclear cells by flow cytometry
and mean telomere length (mTL) was determined by real time
PCR from all study participants. Patients with acute myocardial
infarction had significant shorter mTL in their CD4+ T cells 24 h
after PPCI (2.960.9 vs. 3.560.8 kB, p = 0.01) when compared to
healthy age-matched controls (Figure 5E). 6 months post PPCI,
mTL of CD4+ T cells appeared even shorter (2.5 kB, p = 0.003 vs.
control), suggesting further cell divisions in this cell compartment.
CD4+CCR7+ T cells are specifically depleted from
peripheral blood during myocardial reperfusion
Given that 24 h after PPCI we saw signs of recent proliferation
in the central memory T-cell compartment, the question about the
cause remained. Potential explanations would include myocardial
ischemia preceding PPCI, myocardial reperfusion, or simply
general inflammation. We therefore looked at a second study
population consisting of 17 patients undergoing PPCI. Blood
samples were taken before reopening of the infarct-related artery,
as well as after 30 min, 2 h and 24 h. From these data points we
calculated the relative changes in the resulting time intervals.
Surprisingly, monocytes (Figure 6A) and granulocytes (Figure 6B)
did not show any significant changes following reopening of the
infarct-related artery. In contrast, T cells decreased by 35% during
the first 30 min following reperfusion, only to increase by 6% and
60% in subsequent time intervals (p = 0.0007, Figure 6C).
Measurement of absolute numbers at each time point suggested
that CD4+ T cells might have been slightly reduced before PPCI
(6926422 vs. 8636288 cells/ml, ns, Figure 6D), which in some
cases might have been the result of spontaneous or pharmacolog-
ical (aspirin, prasugrel) reperfusion before reaching the cathlab.
This is reflected by several patients with TIMI1 flow prior to
PPCI. However, the only significant drop in CD4+ T cells
occurred in the first 30 min following reperfusion (4286156 vs.
6926422 cells/ml, p,0.05, Figure 6D). Finally, we performed
polychromatic flow cytometry on 9 of the 17 patients. After
reviewing all clusters, we identified a subset of cells that was
specifically depleted during early reperfusion. CD4+CCR7+ T cells
were reduced by 1276115 cells/ml in the first 30 min, while
CD4+CCR72 T cells only decreased by 29675 cells/ml in the
same time interval (p,0.05, Figure 6E). CD4+CCR7+ T cells,
which also include central memory cells, already started increasing
between 30 min and 2 h following reperfusion (1156183 cells/ml,
Figure 6E). Altogether, this suggests an important role of
CD4+CCR7+ T cells during early reperfusion and potentially
myocardial ischemia/reperfusion injury.
Discussion
Primary PCI has led to a further decline in acute mortality in
patients with acute myocardial infarction in recent years.
Coronary anatomy as well as the time interval between the onset
of ischemia to reopening of the infarct-related vessel represent two
major predictors of infarct size and outcome, prompting ever more
efficient networks to e.g. transport patients directly to 24 h PCI
centers and reduce door-to-balloon-time. However, another major
determinant of infarct size remains myocardial ischemia/reperfu-
sion injury, affecting almost half of successfully treated patients [2–
4]. While coronary angiography finds epicardial flow in the re-
opened artery, cardiac MRI is frequently detecting signs of
microvascular plugging and injury secondary to reperfusion, seen
as microvascular obstruction (MVO) [19]. On a cellular basis
there is no specific parameter at present, that allows for immediate
assessment of reperfusion injury.
Myocardial I/R leads to a sustained inflammatory response,
culminating in a dramatic influx of neutrophil granulocytes into
the infarcting myocardium and their adherence to the endothe-
lium. This in turn leads to capillary plugging, edema and a
reduction in coronary flow. Studies in mouse models of I/R have
identified lymphocytes as the cause of secondary influx of
neutrophils. Specifically, CD4+ T cells migrate to the infarcted
myocardium following reopenening of the infarct vessel [8,9].
Rag1 knockout mice, which lack T and B lymphocytes, are
protected from myocardial I/R injury [9]. Infusion of CD4+ T
cells from interferon-c knockout mice – but not wild type animals -
into Rag1 ko mice fails to increase myocardial injury, suggesting
that interferon-c secreting CD4+ T cells are major contributors to
myocardial I/R injury in the mouse [9]. Interleukin-10, a cytokine
that can suppress interferon-c secreting CD4+ T cells, has been
shown to contribute to cardiac protection after MI in a mouse
model [20]. It is conceivable though, that modelling myocardial I/
R in the mouse does not exactly reflect the human situation,
possibly due to 1) use of infarct models in otherwise young and
healthy mice, 2) differences in the immune system, 3) a
preponderance of lymphocytes as opposed to granulocytes among
leukocytes (up to 70%) in most mouse strains, and 4) the presence
of chronic ischemia pre infarction in some of the patients.
In humans, very little information exists regarding the potential
role of leukocyte components during reperfusion. At least 5 studies
have identified a high concentration of neutrophils and monocytes,
low lymphocyte counts, and high neutrophil to lymphocyte ratio as
predictors of major cardiovascular events or death following
myocardial infarction [10,21–23]. However, none of these studies
has looked into early time intervals following PPCI or identified
cell populations relevant to reperfusion with high accuracy.
Polychromatic flow cytometry represents the only currently
available tool for accurately detecting and characterizing of
phenotypic leukocyte subset diversity in the human immune
system. Although some recent reports presented a simultaneous
flow cytometric quantification of up to 17 different fluorochromes
and dyes [24–26], the reproducibility and practicability of such
complex multiparameter measurements, especially in the context
of large-scale clinical sample screening, often remain insufficient
for widespread use. The limiting factors include lack of simple and
reproducible cell processing and staining protocols, unavailability
of appropriate instruments and/or on-site flow cytometry expertise
(especially in smaller clinical centres), low time and cost efficiency
of polychromatic flow cytometry measurements, as well as
problems with a rapid and objective analysis of complex
multiparameter data. In consequence, many of the potential
Figure 5. Increased expression of CD57 in central memory cells indicates acute proliferation in the CD4 T-cell compartment.
Conventional gating analysis confirmed increased expression of proliferation associated markers CD57 on CM CD4+ T cells of STEMI pts (MFI – mean
fluorescence intensity). This was reflected by significantly increased frequencies of specific KLRG12CD57+ CD4 CM+ T cells (A–C). The validity of CD57,
PD-1 and KLRG1 as proliferation-associated markers was determined in healthy controls according to Sallusto’s model of T-cell differentiation (D).
Mean telomere length (mTL) in CD4+ T cells is reduced in patients with STEMI when compared to age-matched controls (E). *p,0.05, **p,0.01,
***p,0.001, ns not significant.
doi:10.1371/journal.pone.0047155.g005
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Figure 6. CD4+CCR7+ T cells are specifically depleted from peripheral blood during myocardial reperfusion. Time course pilot study
showed no significant changes in numbers of monocytes (A) and granulocytes (B) following PPCI. In contrast, T cells decreased by 35% during the
first 30 min following reperfusion showing significant relative increase within next 24 hours (C). The absolute cell count analysis revealed a significant
decrease in CD4+ T cells during the first 60 min following PPCI (D). This was mainly due to the specific depletion of circulating CD4+CCR7+ cells within
the first 30 min following reperfusion (E). *p,0.05, **p,0.01, ns not significant.
doi:10.1371/journal.pone.0047155.g006
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advantages of multiparameter flow cytometry still remain poorly
applicable for scientists and clinicians across different medical
disciplines, including cardiovascular research.
Our study has provided 3 important results: We have shown for
the first time that analysis of complex immunophenotypic patterns
is possible even in patients with acute myocardial infarction, where
two third of the patients are being treated out of hours. We
managed to develop a standardized protocol for analysis of 13
parameters. Interassay variability was kept at 4%, allowing
excellent comparability of spatial measurements. Flow-sorting of
subpopulations from cryopreserved samples was simple as well,
which allowed DNA isolation and telomere length measurements
specifically in CD4+ T cells. Second, we showed that a recently
developed algorithm, which allowed hierarchical clustering
analysis (HCA), enabled identification of differential cell popula-
tions. Finally, as an example for the practicability of our protocol,
we identified a depletion of CCR7+ CD4+ T cells from peripheral
blood during the first 30 min of reperfusion following PPCI. The
chemokine receptor CCR7 has been identified as a key regulator
of T-cell trafficking to secondary lymphoid organs [27]. However,
CCR7 can also be involved in the abnormal recruitment of T cells
from the peripheral blood to sites of acute inflammation [28].
CCR7 is expressed on naive, central memory and regulatory T
cells [27]. CCL19 and CCL21 are the only ligands of CCR7 and
both are expressed by endothelial cells [27]. Activation of the
ligands leads to recruitment of CCR7-containing naive T cells to
the endothelial layer in lymph nodes, but most likely in other
locations as well. Interestingly, increased levels of CCL19 and
CCL21 in atherosclerotic plaques have been found in stable and
unstable angina [29]. Plasma levels of CCL21 increase up to 3-fold
during the first 2 hours following PCI, and CCL19 levels peak at
24 h post PPCI [29]. Accordingly, genetic knockout of the CCR7
receptor in LDL receptor knockout mice attenuates atherosclerotic
plaque development [27,30]. Importantly, CCR7 signalling
pathways in murine and human T cells are identical [27]. Given
the temporal regulation of both CCR7 ligands during PCI as well
as their role in T-cell trafficking to inflamed sites, it is conceivable
that CCR7 and its two ligands could play an important role in T-
cell migration to the infarcted heart during I/R following primary
PCI.
Multiple clinical trials have attempted to target reperfusion
injury. Antioxidants, reduction of intracellular calcium overload,
antiinflammatory agents, adenosine, metabolic regulation, mag-
nesium, nicorandil as well as therapeutic hypothermia, by large
have failed to achieve significant reduction in infarct size [31] (for
review, see [19]). So far, no trial has targeted T cells directly.
However, the application of the immunosuppressive agent
cyclosporin A prior to reperfusion has proven successful to reduce
infarct size as measured by cardiac MRI and integrated troponin
serum levels [32].
Our study identified for the first time significant T-cell shifts in
patients with myocardial infarction following coronary reperfu-
sion. The fact that these shifts did not occur in other leukocyte
compartments, indicates a specific mechanism. However, it has to
be pointed out that despite the ’’disappearence’’ of T-cells from the
peripheral blood one cannot conclude that the remaining cells
have entered the myocardium. While cell death is an unlikely
explanation, redistribution of T-cells to the bone marrow or
lymphatic tissues such as the spleen could certainly present a
possibility. Future studies, including animal models and, e.g.
measurements of the transcoronary gradients of the selected T-cell
subsets in patients following reperfusion, may provide more
mechanistic evidence. However, T-cell compartment shifts could
be a surrogate marker for the extent of I/R-injury-related
inflammatory response.
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